Publications by authors named "Ho Alan"

Claim this Profile
T
The Use of Proton Radiation in the Management of Adenoid Cystic Carcinoma.
Irini Yacoub, Achraf Shamseddine, Daniel Kallini, Nader Mohamed, Kaveh Zakeri, Alan Ho

Int J Part Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head and Neck Cancer: A Review.
Lara A Dunn, Alan L Ho, David G Pfister

JAMA· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoradionecrosis After Intensity-Modulated Radiation Therapy or Proton Therapy in Oropharyngeal Carcinoma.
Fan Yang, Edward Christopher Dee, Annu Singh, Yingzhi Wu, James O Suggitt, Alan L Ho

JAMA Otolaryngol Head Neck Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evaluation of user engagement with an artificial intelligence-powered clinical trial application in oncology.
Tony K W Hung, Jun J Mao, Alan L Ho, Eric J Sherman, Mark Robson

J Am Med Inform Assoc· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of tumor cell MHC class II drives MAPK inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers.
Vera Tiedje, Jillian Greenberg, Tianyue Qin, Soo-Yeon Im, Gnana P Krishnamoorthy, Alan L Ho

J Clin Invest· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Lara A Dunn, Alan L Ho, Loren S Michel, Winston Wong, Juliana Eng

Oral Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study).
Linda Chen, Marc Cohen, Vaios Hatzglou, Zhigang Zhang, Nadeem Riaz, Alan L Ho

Int J Radiat Oncol Biol Phys· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Vismodegib in Patients With or -Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol T.
Anne S Tsao, Zihe Song, Alan L Ho, Janice M Mehnert, Percy Ivy

JCO Precis Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the potential of computer simulation models in drug testing and biomedical research: a systematic review.
Rahul Mittal, Alan Ho, Harini Adivikolanu, Muskaan Sawhney, Joana R N Lemos

Front Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the cellular tumor microenvironment landscape in salivary gland carcinomas using multiplexed imaging mass cytometry.
Marcel Mayer, Lisa Nachtsheim, Louis Jansen, Philipp Wolber, Marcel Schmiel, Alan L Ho

J Exp Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic Response to Neoadjuvant Cetuximab, Platinum, and Taxane in Locally Advanced HNSCC.
Gabriel Raab, Bin Xu, Anas Alabkaa, Nora Katabi, Snjezana Dogan, Alan L Ho

Otolaryngol Head Neck Surg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proton Therapy for Paranasal Sinus Cancer: Clinical Outcomes and Patterns of Failure.
Caineng Cao, Teeradon Treechairusame, Nadeem Riaz, Sean M McBride, Daphna Y Gelblum, Alan L Ho

Head Neck· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoradionecrosis as a complication following post-operative intensity-modulated radiation therapy or proton therapy for oral cavity cancer.
Teeradon Treechairusame, Annu Singh, Edward Christopher Dee, Jung Hun Oh, Pengpeng Zhang, Alan L Ho

Oral Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue factor expression in salivary gland carcinoma: a potential novel therapeutic target for advanced disease.
Louis Jansen, Lisa Nachtsheim, Philipp Wolber, Sami Shabli, Julia Eßer, Alan L Ho

Ther Adv Med Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sympathetic axonogenesis promotes adenoid cystic carcinoma progression.
Chun-Hao Chen, Boris Reva, Nora Katabi, Avishai Wizel, Hongbo Xu, Alan L Ho

J Exp Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma.
Dan P Zandberg, Jacob B Allred, Ari J Rosenberg, John M Kaczmar, Paul Swiecicki, Alan L Ho

J Clin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter to the Editor From Zhang et al: "Cabozantinib Plus Ipilimumab/Nivolumab in Patients with Previously Treated Advanced Differentiated Thyroid Cancer".
Bhavana Konda, Eric J Sherman, Erminia Massarelli, Jorge Nieva, Jameel Muzaffar, Alan L Ho

J Clin Endocrinol Metab· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement.
Sophie Leboulleux, Laura Boucai, Naifa Busaidy, Cosimo Durante, James A Fagin, Alan Ho

Lancet Diabetes Endocrinol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining response-adapted surgery after neoadjuvant therapy in oral cavity cancer.
Jennifer R Cracchiolo, Michael T Starc, Richard J Wong, Alan Ho, Ian Ganly

Oral Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constructing a Digital Bridge: A Systematic Review Assessing Electronic Medical Record and Telehealth Implementation for Neurosurgery in Uganda.
Caleigh S Roach, Ann Pham, Jacob J Shawwa, Alan Ho, Connor Nee

World Neurosurg· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Results of External Beam Radiation Therapy with or Without Concurrent Chemotherapy in Differentiated Thyroid Cancer.
Justin Choi, Eric Sherman, Edward Christopher Dee, Teeradon Treechairusame, Kaveh Zakeri, Alan L Ho

Thyroid· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions.
Ying-Hsia Chu, Nora Katabi, Purvil Sukhadia, Kerry A Mullaney, Michael Zaidinski, Alan L Ho

Histopathology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma-associated antigen A4: A cancer/testis antigen as a target for adoptive T-cell receptor T-cell therapy.
Gabrielle Knafler, Alan L Ho, Kathleen N Moore, Seth M Pollack, Jean-Marc Navenot

Cancer Treat Rev· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitors.
Vera Tiedje, Jillian Greenberg, Tianyue Qin, Soo-Yeon Im, Gnana P Krishnamoorthy, Alan L Ho

bioRxiv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted RNA Sequencing of Head and Neck Adenoid Cystic Carcinoma Reveals SEC16A::NOTCH1 Fusion and MET Exon 14 Skipping as Potentially Actionable Alterations.
Ying-Hsia Chu, Bin Xu, Purvil Sukhadia, Abhinita S Mohanty, Sara E DiNapoli, Alan L Ho

Head Neck Pathol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis